EntrarCadastrar

/

Crizotinib

CAS 877399-52-5

Visão geral

Crizotinib is an anti-cancer drug acting as an ALK and ROS1 inhibitor, approved for treatment of some non-small cell lung carcinoma in the US and some other countries, and undergoing clinical trials

A Anant Labs fabrica e fornece impurezas de Crizotinib de alta qualidade para o mercado global. Nossas impurezas EP de Crizotinib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Ingrediente Farmacêutico Ativo

Chemical structure of Crizotinib

Crizotinib

Cat. No.: ANT-CZT-00
CAS: 877399-52-5
Mol. Formula: C₂₁H₂₂Cl₂FN₅O
Mol. Weight: 450.34

Impurezas (5)

Chemical structure of Crizotinib Bromide Impurity

Crizotinib Bromide Impurity

Cat. No.: ANT-CZT-02
CAS: 877399-00-3
Mol. Formula: C₁₃H₁₀BrCl₂FN₂O
Mol. Weight: 380.04

Chemical structure of Crizotinib Impurity 1

Crizotinib Impurity 1

Cat. No.: ANT-CZT-04
CAS: NA
Mol. Formula: C₂₅H₃₀Cl₂FN₅O₂
Mol. Weight: 522.45

Chemical structure of Crizotinib Impurity 2

Crizotinib Impurity 2

Cat. No.: ANT-CZT-05
CAS: 877400-66-3
Mol. Formula: C₂₄H₂₈Cl₂FN₅O
Mol. Weight: 492.42

Chemical structure of Crizotinib N-Boc Crizotinib impurity

Crizotinib N-Boc Crizotinib impurity

Cat. No.: ANT-CZT-03
CAS: 877399-51-4
Mol. Formula: C₂₆H₃₀Cl₂FN₅O₃
Mol. Weight: 550.45

Chemical structure of Crizotinib Pinacol boronate Impurity

Crizotinib Pinacol boronate Impurity

Cat. No.: ANT-CZT-01
CAS: 877399-74-1
Mol. Formula: C₁₉H₃₂BN₃O₄
Mol. Weight: 377.29